
Five gamers filed an antitrust class action law suit accusing Valve of forcing developers to list the same prices for their games as in other stores. The suit alleges that this destroys competition.
Valve, whose game distribution service Steam controls 75% of all PC sales, is on the verge of a new trial. According to The Hollywood Reporter, the five gamers accuse the company of requiring developers and publishers to enter into a “Most Favored Nations” (MFN) clause.
It’s the part of the Steam Distribution Agreement that doesn’t allow developers to set lower prices for their games on other platforms. It means that the price of a PC game on Steam should be the same as on any other online store.
“The Steam MFN also hinders innovation by creating an artificial barrier to entry for platforms,” the lawsuit reads. “If this market functioned properly — that is, if the Steam MFN did not exist and platforms were able to compete on price — platforms competing with Steam would be able to provide the same (or higher) margins to game developers while simultaneously providing lower prices to consumers.”
The plaintiffs think that Valve’s policy doesn’t allow platforms like Microsoft Store or Epic Games Store to price games lower. The lawsuit also alleges that it prevents new stores from entering the market.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas